Obesity
Disease education
Review information important to the clinical understanding of obesity and patient care.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
Obesity Management in Racial and Ethnic Minority Individuals
Obesity Related Complications
Obesity Related Complications
Obesity: an overview of the disease - English version
Obesity: an overview of the disease - Spanish version
Impact of obesity in adolescents
Overcoming Racial Disparities in Obesity (IME Content)
Insights and suggestions for overcoming racial disparities in obesity, as obesity affects racial and ethnic groups at various rates.
Obesity Pathophysiology Whiteboard Animation (IME Content)
Whiteboard animation video summarizing pathophysiology of obesity.
Energy Regulation & Dysregulation (IME content)
Detailed breakdown of the complex interplay of internal communication and external cues that dictate energy regulation (or dysregulation) and weight.
Motivational Interviewing: A Component of Clinical Obesity Treatment (IME Content)
2-page infographic reviewing motivational interviewing principles and processes in the context of patients with obesity.
Individualizing Treatment Plans and the Role of Shared Decision-Making (IME content)
Communication skills and other tips for how to partner with obese patients on their path to better health.
Find more information
Find product information
Explore our portfolio of products for treating obesity, including prescribing information, safety data sheets and storage and stability information.
Continuing education
Learn about accredited obesity education opportunities supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
